Related Experiment Video
Updated: Feb 11, 2026
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance
Li Yang1, Jing Chen1, Xi Huang1
1Multiple Myeloma Treatment Center & Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China.
Abstract:
Drug resistance can obstruct successful cancer chemotherapy. The ubiquitin-proteasome pathway has emerged as a crucial player that controls steady-state protein levels regulating multiple biological processes, such as cell cycle, cellular proliferation, apoptosis, and DNA damage response, which are involved in oncogenesis, cancer development, prognosis, and drug resistance. E3 ligases perform the final step in the ubiquitination cascade, and determine which protein becomes ubiquitylated by specifically binding the substrate protein. They are promising drug targets thanks to their ability to regulate protein stability and functions. Although patient survival has increased in recent years with the availability of novel agents, chemoresistance remains a major problem in cancer management. E3 ligases attract increasing attention with advances in chemoresistance knowledge. To explore the role of E3 ligase in cancer chemotherapy resistance and the underlying mechanism, we summarize the growing number of E3 ligases and their substrate proteins, which have emerged as crucial players in cancer chemoresistance and targeted therapies.
Insights
Drug resistance hinders cancer chemotherapy. E3 ligases, key regulators of protein stability, are crucial in overcoming this resistance and represent promising targets for novel cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Drug resistance is a significant obstacle in cancer chemotherapy, impacting patient outcomes.
- The ubiquitin-proteasome pathway regulates critical cellular processes involved in cancer development and drug resistance.
- E3 ligases, as key components of this pathway, control protein stability and are implicated in oncogenesis and chemoresistance.
Purpose of the Study:
- To explore the role of E3 ligases in cancer chemotherapy resistance.
- To elucidate the underlying mechanisms by which E3 ligases influence chemoresistance.
- To summarize the current understanding of E3 ligases and their substrates in the context of cancer treatment.
Main Methods:
- Literature review and synthesis of existing research on E3 ligases and cancer chemoresistance.
- Analysis of the function of various E3 ligases and their specific substrate proteins.
- Examination of the link between E3 ligase activity and cellular processes relevant to drug resistance.
Main Results:
- E3 ligases play a critical role in regulating protein stability, influencing cell cycle, proliferation, apoptosis, and DNA damage response.
- Dysregulation of specific E3 ligases is associated with the development of chemoresistance in various cancers.
- Numerous E3 ligases and their substrates have been identified as crucial players in cancer chemoresistance.
Conclusions:
- E3 ligases are pivotal in managing protein homeostasis and are increasingly recognized for their involvement in cancer drug resistance.
- Targeting E3 ligases offers a promising therapeutic strategy to overcome chemoresistance.
- Further research into E3 ligase substrates and their mechanisms is essential for developing effective targeted cancer therapies.
Related Concept Videos
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:18Cancer
02:18The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:12What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
01:57Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...